Thallion
Thallion engages in developing and commercializing monoclonal antibody therapeutics for the treatment of oncology and infectious diseases.
Business Model:
Revenue: $2.5M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Thallion Information
Thallion was acquired by
Taro Pharmaceuticals.
The acquisition happend on 2017-03-17.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 1375 Autoroute Trans-Canadienne
City: Dorval
State: quebec
Zip: H9P 2W8
Country: CA
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Thallion engages in developing and commercializing monoclonal antibody therapeutics for the treatment of oncology and infectious diseases.
Contact Phone:
+15149403600
Contact Email:
Thallion went public on the TMX Group - Toronto Stock Exchange
Listed Exchange:
TMX Group - Toronto Stock Exchange
Ticker Symbol:
TLN
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
